Lack of effect of clonidine on stuttering in children. 1995

M Althaus, and H J Vink, and R B Minderaa, and S M Goorhuis-Brouwer, and M D Oosterhoff
University Center of Child and Adolescent Psychiatry, Groningen, The Netherlands.

OBJECTIVE The authors studied the effects of the alpha 2-receptor agonist clonidine on stuttering in children. METHODS Using a double-blind crossover study, they gave placebo or 4 micrograms/kg body weight per day to 25 stuttering children who were 6-13 years old. Stuttering was measured by counting the occurrences of four elementary speech difficulties and by asking parents and teachers to give an overall impression of the amount of stuttering, as well as their impression of how troublesome the stuttering was to the children. RESULTS Clonidine did not improve stuttering. CONCLUSIONS Clonidine cannot be recommended as a useful drug for treating children who stutter.

UI MeSH Term Description Entries
D001835 Body Weight The mass or quantity of heaviness of an individual. It is expressed by units of pounds or kilograms. Body Weights,Weight, Body,Weights, Body
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D003000 Clonidine An imidazoline sympatholytic agent that stimulates ALPHA-2 ADRENERGIC RECEPTORS and central IMIDAZOLINE RECEPTORS. It is commonly used in the management of HYPERTENSION. Catapres,Catapresan,Catapressan,Chlophazolin,Clofelin,Clofenil,Clonidine Dihydrochloride,Clonidine Hydrochloride,Clonidine Monohydrobromide,Clonidine Monohydrochloride,Clopheline,Dixarit,Gemiton,Hemiton,Isoglaucon,Klofelin,Klofenil,M-5041T,ST-155,Dihydrochloride, Clonidine,Hydrochloride, Clonidine,M 5041T,M5041T,Monohydrobromide, Clonidine,Monohydrochloride, Clonidine,ST 155,ST155
D004311 Double-Blind Method A method of studying a drug or procedure in which both the subjects and investigators are kept unaware of who is actually getting which specific treatment. Double-Masked Study,Double-Blind Study,Double-Masked Method,Double Blind Method,Double Blind Study,Double Masked Method,Double Masked Study,Double-Blind Methods,Double-Blind Studies,Double-Masked Methods,Double-Masked Studies,Method, Double-Blind,Method, Double-Masked,Methods, Double-Blind,Methods, Double-Masked,Studies, Double-Blind,Studies, Double-Masked,Study, Double-Blind,Study, Double-Masked
D004334 Drug Administration Schedule Time schedule for administration of a drug in order to achieve optimum effectiveness and convenience. Administration Schedule, Drug,Administration Schedules, Drug,Drug Administration Schedules,Schedule, Drug Administration,Schedules, Drug Administration
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D013342 Stuttering A disturbance in the normal fluency and time patterning of speech that is inappropriate for the individual's age. This disturbance is characterized by frequent repetitions or prolongations of sounds or syllables. Various other types of speech dysfluencies may also be involved including interjections, broken words, audible or silent blocking, circumlocutions, words produced with an excess of physical tension, and monosyllabic whole word repetitions. Stuttering may occur as a developmental condition in childhood or as an acquired disorder which may be associated with BRAIN INFARCTIONS and other BRAIN DISEASES. (From DSM-IV, 1994) Stammering,Stuttering, Acquired,Stuttering, Adult,Stuttering, Childhood,Stuttering, Developmental,Stuttering, Familial Persistent 1,Acquired Stuttering,Adult Stuttering,Childhood Stuttering,Developmental Stuttering
D016896 Treatment Outcome Evaluation undertaken to assess the results or consequences of management and procedures used in combating disease in order to determine the efficacy, effectiveness, safety, and practicability of these interventions in individual cases or series. Rehabilitation Outcome,Treatment Effectiveness,Clinical Effectiveness,Clinical Efficacy,Patient-Relevant Outcome,Treatment Efficacy,Effectiveness, Clinical,Effectiveness, Treatment,Efficacy, Clinical,Efficacy, Treatment,Outcome, Patient-Relevant,Outcome, Rehabilitation,Outcome, Treatment,Outcomes, Patient-Relevant,Patient Relevant Outcome,Patient-Relevant Outcomes
D018592 Cross-Over Studies Studies comparing two or more treatments or interventions in which the subjects or patients, upon completion of the course of one treatment, are switched to another. In the case of two treatments, A and B, half the subjects are randomly allocated to receive these in the order A, B and half to receive them in the order B, A. A criticism of this design is that effects of the first treatment may carry over into the period when the second is given. (Last, A Dictionary of Epidemiology, 2d ed) Cross-Over Design,Cross-Over Trials,Crossover Design,Crossover Studies,Crossover Trials,Cross Over Design,Cross Over Studies,Cross Over Trials,Cross-Over Designs,Cross-Over Study,Crossover Designs,Crossover Study,Design, Cross-Over,Design, Crossover,Designs, Cross-Over,Designs, Crossover,Studies, Cross-Over,Studies, Crossover,Study, Cross-Over,Study, Crossover,Trial, Cross-Over,Trial, Crossover,Trials, Cross-Over,Trials, Crossover

Related Publications

M Althaus, and H J Vink, and R B Minderaa, and S M Goorhuis-Brouwer, and M D Oosterhoff
November 1987, Prostaglandins, leukotrienes, and medicine,
M Althaus, and H J Vink, and R B Minderaa, and S M Goorhuis-Brouwer, and M D Oosterhoff
January 1990, Clinical pharmacology and therapeutics,
M Althaus, and H J Vink, and R B Minderaa, and S M Goorhuis-Brouwer, and M D Oosterhoff
September 2008, Journal of fluency disorders,
M Althaus, and H J Vink, and R B Minderaa, and S M Goorhuis-Brouwer, and M D Oosterhoff
August 2000, Journal of pineal research,
M Althaus, and H J Vink, and R B Minderaa, and S M Goorhuis-Brouwer, and M D Oosterhoff
September 1953, Meditsinskaia sestra,
M Althaus, and H J Vink, and R B Minderaa, and S M Goorhuis-Brouwer, and M D Oosterhoff
October 1972, Lille medical : journal de la Faculte de medecine et de pharmacie de l'Universite de Lille,
M Althaus, and H J Vink, and R B Minderaa, and S M Goorhuis-Brouwer, and M D Oosterhoff
August 2009, Kinderkrankenschwester : Organ der Sektion Kinderkrankenpflege,
M Althaus, and H J Vink, and R B Minderaa, and S M Goorhuis-Brouwer, and M D Oosterhoff
October 1967, Journal of abnormal psychology,
M Althaus, and H J Vink, and R B Minderaa, and S M Goorhuis-Brouwer, and M D Oosterhoff
June 1959, Northwest medicine,
M Althaus, and H J Vink, and R B Minderaa, and S M Goorhuis-Brouwer, and M D Oosterhoff
January 1988, Neurobiology of aging,
Copied contents to your clipboard!